The global market for Musculoskeletal Disorders Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Musculoskeletal Disorders Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Musculoskeletal Disorders Therapeutics by region & country, by Type, and by Application.

The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal Disorders Therapeutics.

Market Segmentation

Scope of Musculoskeletal Disorders Therapeutics - Market Report

Report Metric	Details
Report Name	Musculoskeletal Disorders Therapeutics - Market
CAGR	5%
Segment by Type:	Biologics Small Molecules
Segment by Application	Osteoarthritis Osteoporosis Psoriatic Arthritis Ankylosing Spondylitis Fibromyalgia
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Musculoskeletal Disorders Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Musculoskeletal Disorders Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Musculoskeletal Disorders Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Musculoskeletal Disorders Therapeutics - Market report?

Ans: The main players in the Musculoskeletal Disorders Therapeutics - Market are AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences

What are the Application segmentation covered in the Musculoskeletal Disorders Therapeutics - Market report?

Ans: The Applications covered in the Musculoskeletal Disorders Therapeutics - Market report are Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia

What are the Type segmentation covered in the Musculoskeletal Disorders Therapeutics - Market report?

Ans: The Types covered in the Musculoskeletal Disorders Therapeutics - Market report are Biologics, Small Molecules

1 Market Overview

1.1 Musculoskeletal Disorders Therapeutics Product Introduction

1.2 Global Musculoskeletal Disorders Therapeutics Market Size Forecast

1.3 Musculoskeletal Disorders Therapeutics Market Trends & Drivers

1.3.1 Musculoskeletal Disorders Therapeutics Industry Trends

1.3.2 Musculoskeletal Disorders Therapeutics Market Drivers & Opportunity

1.3.3 Musculoskeletal Disorders Therapeutics Market Challenges

1.3.4 Musculoskeletal Disorders Therapeutics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Musculoskeletal Disorders Therapeutics Players Revenue Ranking (2023)

2.2 Global Musculoskeletal Disorders Therapeutics Revenue by Company (2019-2024)

2.3 Key Companies Musculoskeletal Disorders Therapeutics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Musculoskeletal Disorders Therapeutics Product Offered

2.5 Key Companies Time to Begin Mass Production of Musculoskeletal Disorders Therapeutics

2.6 Musculoskeletal Disorders Therapeutics Market Competitive Analysis

2.6.1 Musculoskeletal Disorders Therapeutics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Musculoskeletal Disorders Therapeutics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Biologics

3.1.2 Small Molecules

3.2 Global Musculoskeletal Disorders Therapeutics Sales Value by Type

3.2.1 Global Musculoskeletal Disorders Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Musculoskeletal Disorders Therapeutics Sales Value, by Type (2019-2030)

3.2.3 Global Musculoskeletal Disorders Therapeutics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Osteoarthritis

4.1.2 Osteoporosis

4.1.3 Psoriatic Arthritis

4.1.4 Ankylosing Spondylitis

4.1.5 Fibromyalgia

4.2 Global Musculoskeletal Disorders Therapeutics Sales Value by Application

4.2.1 Global Musculoskeletal Disorders Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Musculoskeletal Disorders Therapeutics Sales Value, by Application (2019-2030)

4.2.3 Global Musculoskeletal Disorders Therapeutics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Musculoskeletal Disorders Therapeutics Sales Value by Region

5.1.1 Global Musculoskeletal Disorders Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2019-2024)

5.1.3 Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2025-2030)

5.1.4 Global Musculoskeletal Disorders Therapeutics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

5.2.2 North America Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

5.3.2 Europe Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

5.4.2 Asia Pacific Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

5.5.2 South America Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

5.6.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value

6.3 United States

6.3.1 United States Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.3.2 United States Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.4.2 Europe Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.5.2 China Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.6.2 Japan Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.7.2 South Korea Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.8.2 Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Musculoskeletal Disorders Therapeutics Sales Value, 2019-2030

6.9.2 India Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Musculoskeletal Disorders Therapeutics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AbbVie

7.1.1 AbbVie Profile

7.1.2 AbbVie Main Business

7.1.3 AbbVie Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.1.4 AbbVie Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.1.5 AbbVie Recent Developments

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Profile

7.2.2 Johnson & Johnson Main Business

7.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.2.4 Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.2.5 Johnson & Johnson Recent Developments

7.3 Amgen

7.3.1 Amgen Profile

7.3.2 Amgen Main Business

7.3.3 Amgen Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.3.4 Amgen Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.3.5 Pfizer Recent Developments

7.4 Pfizer

7.4.1 Pfizer Profile

7.4.2 Pfizer Main Business

7.4.3 Pfizer Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.4.4 Pfizer Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.4.5 Pfizer Recent Developments

7.5 F. Hoffmann-La Roche

7.5.1 F. Hoffmann-La Roche Profile

7.5.2 F. Hoffmann-La Roche Main Business

7.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.5.4 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.5.5 F. Hoffmann-La Roche Recent Developments

7.6 Eli Lilly

7.6.1 Eli Lilly Profile

7.6.2 Eli Lilly Main Business

7.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.6.4 Eli Lilly Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.6.5 Eli Lilly Recent Developments

7.7 Merck

7.7.1 Merck Profile

7.7.2 Merck Main Business

7.7.3 Merck Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.7.4 Merck Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.7.5 Merck Recent Developments

7.8 Novartis

7.8.1 Novartis Profile

7.8.2 Novartis Main Business

7.8.3 Novartis Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.8.4 Novartis Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.8.5 Novartis Recent Developments

7.9 AstraZeneca

7.9.1 AstraZeneca Profile

7.9.2 AstraZeneca Main Business

7.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.9.4 AstraZeneca Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.9.5 AstraZeneca Recent Developments

7.10 Astellas

7.10.1 Astellas Profile

7.10.2 Astellas Main Business

7.10.3 Astellas Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.10.4 Astellas Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.10.5 Astellas Recent Developments

7.11 AB Sciences

7.11.1 AB Sciences Profile

7.11.2 AB Sciences Main Business

7.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.11.4 AB Sciences Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.11.5 AB Sciences Recent Developments

7.12 3SBio

7.12.1 3SBio Profile

7.12.2 3SBio Main Business

7.12.3 3SBio Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.12.4 3SBio Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.12.5 3SBio Recent Developments

7.13 Samsung Bioepis

7.13.1 Samsung Bioepis Profile

7.13.2 Samsung Bioepis Main Business

7.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.13.4 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.13.5 Samsung Bioepis Recent Developments

7.14 Sanofi

7.14.1 Sanofi Profile

7.14.2 Sanofi Main Business

7.14.3 Sanofi Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.14.4 Sanofi Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.14.5 Sanofi Recent Developments

7.15 Taisho Pharmaceutical

7.15.1 Taisho Pharmaceutical Profile

7.15.2 Taisho Pharmaceutical Main Business

7.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.15.4 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.15.5 Taisho Pharmaceutical Recent Developments

7.16 Takeda

7.16.1 Takeda Profile

7.16.2 Takeda Main Business

7.16.3 Takeda Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.16.4 Takeda Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.16.5 Takeda Recent Developments

7.17 Zosano Pharma

7.17.1 Zosano Pharma Profile

7.17.2 Zosano Pharma Main Business

7.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.17.4 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.17.5 Zosano Pharma Recent Developments

7.18 LG Life Sciences

7.18.1 LG Life Sciences Profile

7.18.2 LG Life Sciences Main Business

7.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions

7.18.4 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2019-2024)

7.18.5 LG Life Sciences Recent Developments

8 Industry Chain Analysis

8.1 Musculoskeletal Disorders Therapeutics Industrial Chain

8.2 Musculoskeletal Disorders Therapeutics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Musculoskeletal Disorders Therapeutics Sales Model

8.5.2 Sales Channel

8.5.3 Musculoskeletal Disorders Therapeutics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Taisho Pharmaceutical

Takeda

Zosano Pharma

LG Life Sciences

List of Tables

Table 1. Musculoskeletal Disorders Therapeutics Market Trends

Table 2. Musculoskeletal Disorders Therapeutics Market Drivers & Opportunity

Table 3. Musculoskeletal Disorders Therapeutics Market Challenges

Table 4. Musculoskeletal Disorders Therapeutics Market Restraints

Table 5. Global Musculoskeletal Disorders Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Musculoskeletal Disorders Therapeutics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Musculoskeletal Disorders Therapeutics Product Type

Table 9. Key Companies Time to Begin Mass Production of Musculoskeletal Disorders Therapeutics

Table 10. Global Musculoskeletal Disorders Therapeutics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Musculoskeletal Disorders Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Musculoskeletal Disorders Therapeutics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Musculoskeletal Disorders Therapeutics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Musculoskeletal Disorders Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Musculoskeletal Disorders Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Musculoskeletal Disorders Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Musculoskeletal Disorders Therapeutics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Musculoskeletal Disorders Therapeutics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Musculoskeletal Disorders Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Musculoskeletal Disorders Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Musculoskeletal Disorders Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2019-2024) & (%)

Table 27. Global Musculoskeletal Disorders Therapeutics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value, (2025-2030) & (US$ Million)

Table 31. AbbVie Basic Information List

Table 32. AbbVie Description and Business Overview

Table 33. AbbVie Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of AbbVie (2019-2024)

Table 35. AbbVie Recent Developments

Table 36. Johnson & Johnson Basic Information List

Table 37. Johnson & Johnson Description and Business Overview

Table 38. Johnson & Johnson Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Johnson & Johnson (2019-2024)

Table 40. Johnson & Johnson Recent Developments

Table 41. Amgen Basic Information List

Table 42. Amgen Description and Business Overview

Table 43. Amgen Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Amgen (2019-2024)

Table 45. Amgen Recent Developments

Table 46. Pfizer Basic Information List

Table 47. Pfizer Description and Business Overview

Table 48. Pfizer Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Pfizer (2019-2024)

Table 50. Pfizer Recent Developments

Table 51. F. Hoffmann-La Roche Basic Information List

Table 52. F. Hoffmann-La Roche Description and Business Overview

Table 53. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of F. Hoffmann-La Roche (2019-2024)

Table 55. F. Hoffmann-La Roche Recent Developments

Table 56. Eli Lilly Basic Information List

Table 57. Eli Lilly Description and Business Overview

Table 58. Eli Lilly Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Eli Lilly (2019-2024)

Table 60. Eli Lilly Recent Developments

Table 61. Merck Basic Information List

Table 62. Merck Description and Business Overview

Table 63. Merck Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Merck (2019-2024)

Table 65. Merck Recent Developments

Table 66. Novartis Basic Information List

Table 67. Novartis Description and Business Overview

Table 68. Novartis Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Novartis (2019-2024)

Table 70. Novartis Recent Developments

Table 71. AstraZeneca Basic Information List

Table 72. AstraZeneca Description and Business Overview

Table 73. AstraZeneca Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of AstraZeneca (2019-2024)

Table 75. AstraZeneca Recent Developments

Table 76. Astellas Basic Information List

Table 77. Astellas Description and Business Overview

Table 78. Astellas Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Astellas (2019-2024)

Table 80. Astellas Recent Developments

Table 81. AB Sciences Basic Information List

Table 82. AB Sciences Description and Business Overview

Table 83. AB Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 84. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of AB Sciences (2019-2024)

Table 85. AB Sciences Recent Developments

Table 86. 3SBio Basic Information List

Table 87. 3SBio Description and Business Overview

Table 88. 3SBio Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 89. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of 3SBio (2019-2024)

Table 90. 3SBio Recent Developments

Table 91. Samsung Bioepis Basic Information List

Table 92. Samsung Bioepis Description and Business Overview

Table 93. Samsung Bioepis Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 94. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Samsung Bioepis (2019-2024)

Table 95. Samsung Bioepis Recent Developments

Table 96. Sanofi Basic Information List

Table 97. Sanofi Description and Business Overview

Table 98. Sanofi Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 99. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Sanofi (2019-2024)

Table 100. Sanofi Recent Developments

Table 101. Taisho Pharmaceutical Basic Information List

Table 102. Taisho Pharmaceutical Description and Business Overview

Table 103. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 104. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Taisho Pharmaceutical (2019-2024)

Table 105. Taisho Pharmaceutical Recent Developments

Table 106. Takeda Basic Information List

Table 107. Takeda Description and Business Overview

Table 108. Takeda Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 109. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Takeda (2019-2024)

Table 110. Takeda Recent Developments

Table 111. Zosano Pharma Basic Information List

Table 112. Zosano Pharma Description and Business Overview

Table 113. Zosano Pharma Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 114. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of Zosano Pharma (2019-2024)

Table 115. Zosano Pharma Recent Developments

Table 116. LG Life Sciences Basic Information List

Table 117. LG Life Sciences Description and Business Overview

Table 118. LG Life Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions

Table 119. Revenue (US$ Million) in Musculoskeletal Disorders Therapeutics Business of LG Life Sciences (2019-2024)

Table 120. LG Life Sciences Recent Developments

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Musculoskeletal Disorders Therapeutics Downstream Customers

Table 124. Musculoskeletal Disorders Therapeutics Distributors List

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Musculoskeletal Disorders Therapeutics Product Picture

Figure 2. Global Musculoskeletal Disorders Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 4. Musculoskeletal Disorders Therapeutics Report Years Considered

Figure 5. Global Musculoskeletal Disorders Therapeutics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2023

Figure 7. Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Biologics Picture

Figure 9. Small Molecules Picture

Figure 10. Global Musculoskeletal Disorders Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Musculoskeletal Disorders Therapeutics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Osteoarthritis

Figure 13. Product Picture of Osteoporosis

Figure 14. Product Picture of Psoriatic Arthritis

Figure 15. Product Picture of Ankylosing Spondylitis

Figure 16. Product Picture of Fibromyalgia

Figure 17. Global Musculoskeletal Disorders Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Musculoskeletal Disorders Therapeutics Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Musculoskeletal Disorders Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Musculoskeletal Disorders Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Musculoskeletal Disorders Therapeutics Sales Value (%), (2019-2030)

Figure 30. United States Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 36. China Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 38. China Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 48. India Musculoskeletal Disorders Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Musculoskeletal Disorders Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 50. India Musculoskeletal Disorders Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 51. Musculoskeletal Disorders Therapeutics Industrial Chain

Figure 52. Musculoskeletal Disorders Therapeutics Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions